These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9360425

  • 1. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G.
    Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
    [Abstract] [Full Text] [Related]

  • 2. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 3. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic treatment of schizophrenia.
    Levinson DF.
    Clin Ther; 1991 Apr; 13(3):326-52. PubMed ID: 1683269
    [Abstract] [Full Text] [Related]

  • 5. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M, Kumar A, Chopra K, Kulkarni SK.
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [Abstract] [Full Text] [Related]

  • 6. [Clozapine and resistant schizophrenia].
    Pere JJ, Chaumet-Riffaud D.
    Encephale; 1990 Feb; 16(2):143-5. PubMed ID: 1972053
    [Abstract] [Full Text] [Related]

  • 7. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 8. [The atypical neuroleptic concept].
    Azorin JM, Dassa D, Jalfre M.
    Encephale; 1992 Sep; 18 Spec No 3():453-7. PubMed ID: 1364079
    [Abstract] [Full Text] [Related]

  • 9. [Atypical neuroleptics in the child and adolescent].
    Naja WJ, Reneric JP, Bouvard MP.
    Encephale; 1998 Sep; 24(4):378-85. PubMed ID: 9809243
    [Abstract] [Full Text] [Related]

  • 10. New drugs for schizophrenia: an update for family physicians.
    Amadio PB, Cross LB, Amadio P.
    Am Fam Physician; 1997 Sep 15; 56(4):1149-56, 1159-60. PubMed ID: 9310066
    [Abstract] [Full Text] [Related]

  • 11. [Atypical neuroleptics. Review of the available clinical data].
    Verhoeven WM, Den Boer JA.
    Encephale; 1990 Sep 15; 16(6):439-44. PubMed ID: 1983216
    [Abstract] [Full Text] [Related]

  • 12. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY, Li Z, Kaneda Y, Ichikawa J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct 15; 27(7):1159-72. PubMed ID: 14642974
    [Abstract] [Full Text] [Related]

  • 13. [Atypical neuroleptics--the future of schizophrenia treatment?].
    Ebert D.
    Fortschr Med; 1998 Jan 30; 116(3):22-8. PubMed ID: 9522541
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia.
    Cohen JD, Van Putten T, Marder S, Berger PA, Stahl SM.
    J Clin Psychopharmacol; 1987 Oct 30; 7(5):324-9. PubMed ID: 2890671
    [Abstract] [Full Text] [Related]

  • 15. [Atypical neuroleptics, pharmacology and clinical importance].
    Klages U, Hippius H, Müller-Spahn F.
    Fortschr Neurol Psychiatr; 1993 Nov 30; 61(11):390-8. PubMed ID: 7903656
    [Abstract] [Full Text] [Related]

  • 16. Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.
    Svensson TH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct 30; 27(7):1145-58. PubMed ID: 14642973
    [Abstract] [Full Text] [Related]

  • 17. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO.
    Encephale; 1995 Jun 30; 21 Spec No 3():49-52. PubMed ID: 7628342
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ.
    J Coll Physicians Surg Pak; 2006 Aug 30; 16(8):556-62. PubMed ID: 16899192
    [Abstract] [Full Text] [Related]

  • 19. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.
    Millan MJ.
    J Pharmacol Exp Ther; 2000 Dec 30; 295(3):853-61. PubMed ID: 11082417
    [Abstract] [Full Text] [Related]

  • 20. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC, Lung FW, Chong MY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 30; 28(2):285-90. PubMed ID: 14751424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.